Latest Orphan drugs Stories
Designation would provide study protocol assistance and market exclusivity PETACH TIKVA, Israel, April 20, 2015 /PRNewswire/ -- Can-Fite
RnRMarketResearch.com adds "Pulmonary Hypertension - Pipeline Review, H1 2015" to its store.
SARATOGA, Calif., March 18, 2015 /PRNewswire/ -- Selten Pharma, Inc., a privatively held biopharmaceutical company focused
CDR recommendation limits specialists' ability to prescribe new medication VANCOUVER, March 5, 2015 /CNW/ - Canadians affected by pulmonary arterial hypertension (PAH) fear
NORWALK, Conn., March 5, 2015 /PRNewswire/ -- UBM Medica US announces that OncoTherapy Network,
Initiation of Registrational Studies Planned for This Year MORRISTOWN, N.J., Jan.
- Data Show Significant Survival Improvement with CPX-351 in Poor-Risk Patients - EWING, N.J., Jan. 12, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
New report from Kantar Health shows opportunities for biosimilars are high in oncology, low in rheumatoid arthritis in China. Shanghai, China (PRWEB) December
SAN DIEGO, Dec. 22, 2014 /PRNewswire/ -- MEI Pharma, Inc.
Expects to complete submission in the first half of 2015 DUBLIN, Dec.
- Growing in low tufty patches.